Leukocare receives VC financing; Mushroom inhalers to debut soon?;

> Germany's Leukocare announced a financing led by LifeCare Partners in support of its Stabilizing and Protecting Solutions offerings to enhance the thermal stability and shelf life of biologics and vaccines. More

> Celine Park, a student at the Royal College of Art, says so-called fungal inhalers could someday be used to administer vaccines by attaching weakened forms a of virus to fungal spores. "Mold spores are very easy to transport to our lungs," she said, adding, "It can easily transmit to surrounding people so they can easily get herd immunity as well--just like flu or pneumonia." More

Suggested Articles

Armed with microrobots and magnetic fields, Pursue scientists are looking to the future of targeted drug delivery, starting with the colon.

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.